These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2363393)

  • 1. Valued services: are they provided?
    Goodman DG
    Am Pharm; 1990 Jul; NS30(7):4. PubMed ID: 2363393
    [No Abstract]   [Full Text] [Related]  

  • 2. Reimbursement for pharmacy cognitive services and health care reform: are they compatible?
    Miller LG
    Pharmacotherapy; 1994; 14(4):506-7. PubMed ID: 7937291
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursement for nondispensing functions: today's innovation is tomorrow's tradition.
    Miller JW
    Contemp Pharm Pract; 1979; 2(2):95-8. PubMed ID: 10297463
    [No Abstract]   [Full Text] [Related]  

  • 4. Quebec turnaround.
    Gariepy Y
    Am Pharm; 1993 Jul; NS33(7):5. PubMed ID: 8342498
    [No Abstract]   [Full Text] [Related]  

  • 5. Obtaining reimbursement for oncology pharmacy services provided to ambulatory patients.
    Chong SF; Rospond RM
    Am J Hosp Pharm; 1993 Oct; 50(10):2057-8. PubMed ID: 8238043
    [No Abstract]   [Full Text] [Related]  

  • 6. Billing third party payers for pharmaceutical care services.
    Poirier S; Buffington DE; Memoli GA
    J Am Pharm Assoc (Wash); 1999; 39(1):50-64; quiz 101-2. PubMed ID: 9990188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursement for cognitive pharmacy services.
    Navarro RP
    Manag Care Interface; 1998 Jul; 11(7):57-9. PubMed ID: 10181571
    [No Abstract]   [Full Text] [Related]  

  • 8. Competitive incentive program. Analysis and proposal.
    Stone J
    Am Pharm; 1986 Jul; NS26(7):45-9. PubMed ID: 3529904
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

  • 10. Payment for cognitive services: the future of the profession.
    Am Pharm; 1989 Dec; NS29(12):34-8. PubMed ID: 2688385
    [No Abstract]   [Full Text] [Related]  

  • 11. Medication therapy management may finally enter the mainstream.
    Sipkoff M
    Manag Care; 2007 May; 16(5):13-4. PubMed ID: 17552332
    [No Abstract]   [Full Text] [Related]  

  • 12. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 13. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 14. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacist in the HMO environment.
    Middleton JK; Dee DA
    Contemp Pharm Pract; 1980; 3(4):268-70. PubMed ID: 10248869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japan: huge profit from drugs.
    Swinbanks D
    Nature; 1989 Nov; 342(6248):333. PubMed ID: 2586595
    [No Abstract]   [Full Text] [Related]  

  • 17. The pay puzzle.
    Goddard H
    CPJ; 1988 Aug; 121(8):490-1. PubMed ID: 10289987
    [No Abstract]   [Full Text] [Related]  

  • 18. Performing and billing for cognitive services: implications for the US.
    Rupp MT
    Ann Pharmacother; 2000 Mar; 34(3):401-2. PubMed ID: 10917390
    [No Abstract]   [Full Text] [Related]  

  • 19. Eight steps toward payment for cognitive services.
    Perri M
    Am Pharm; 1995 Sep; NS35(9):20-4. PubMed ID: 7484812
    [No Abstract]   [Full Text] [Related]  

  • 20. Winning payment for cognitive services: what works.
    Constantine LM; Scott S
    Am Pharm; 1995 Sep; NS35(9):14-9. PubMed ID: 7484811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.